For the sensitivity analysis, of 878 patients (97%) had an albumin-corrected Ca ≥ 2.1 mmol/L value available at cinacalcet initiation, 395 (45%) subsequently developed hypocalcemia (Online Resource 1). The gene discussed is ALB; the disease is Hypocalcemia.